Rothfuss Cristin 4
4 · Sarepta Therapeutics, Inc. · Filed Sep 5, 2025
Insider Transaction Report
Form 4
Rothfuss Cristin
EVP, General Counsel
Transactions
- Award
Common Stock
2025-09-03+93,875→ 114,985 total - Award
Common Stock
2025-09-03+25,000→ 139,985 total
Footnotes (2)
- [F1]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 50% of the RSUs will vest on September 3, 2026, and the remaining 50% will vest on September 3, 2027, subject to the Reporting Person's continued service to the Company.
- [F2]The Reporting Person was granted restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock. 100% of the RSUs will vest on September 3, 2028, subject to the Reporting Person's continued service to the Company and only if certain performance criteria has been deemed achieved by the Compensation Committee of the Board.